Corvus 制药 CRVS
$10.54 +$0.81 (+8.32%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $10.60 +0.57%
开盘$10.65
昨收$9.73
当日区间$9.64 – $10.96
成交量1.26M
市值$889.08M
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数4
平均目标价$28.75+172.8% 较现价
- 买入 100%
最低 $27.00现价 $10.54均值 $28.75最高 $33.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$27.00至$40.00，平均为$30.65。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 29 Oct 2026 | Mizuho Securities | BUY | $27.00 |
| 11 Aug 2026 | Mizuho Securities | BUY | $30.00 |
| 10 Aug 2026 | H.C. Wainwright | BUY | $27.00 |
| 7 Aug 2026 | Barclays | BUY | $28.00 |
| 7 Aug 2026 | Oppenheimer | BUY | $33.00 |
| 1 Jul 2026 | H.C. Wainwright | BUY | $27.00 |
| 12 Jun 2026 | Mizuho Securities | BUY | $30.00 |
| 18 May 2026 | Mizuho Securities | BUY | $30.00 |
| 15 May 2026 | H.C. Wainwright | BUY | $27.00 |
| 15 May 2026 | Barclays | BUY | $28.00 |
| 14 May 2026 | Goldman Sachs | BUY | $40.00 |
| 11 May 2026 | Mizuho Securities | BUY | $30.00 |
| 11 May 2026 | Goldman Sachs | BUY | $40.00 |
| 8 May 2026 | Barclays | BUY | $28.00 |
| 17 Apr 2026 | Goldman Sachs | BUY | $40.00 |
| 16 Mar 2026 | Mizuho Securities | BUY | $30.00 |
| 16 Mar 2026 | Barclays | BUY | $28.00 |
| 13 Mar 2026 | H.C. Wainwright | BUY | $27.00 |
| 13 Mar 2026 | Oppenheimer | BUY | $33.00 |
| 19 Feb 2026 | Mizuho Securities | BUY | $30.00 |
暂无评论——快来第一个聊聊 CRVS。
登录后参与讨论。